MP1.AX vs. VRTX
MP1.AX (Megaport Limited) and VRTX (Vertex Pharmaceuticals Incorporated) are both stocks. MP1.AX operates in Software - Infrastructure (Technology), while VRTX operates in Biotechnology (Healthcare). Over the past 10 years, MP1.AX returned 22.24%/yr vs 16.59%/yr for VRTX. At a correlation of -0.01, they often move in opposite directions.
Performance
MP1.AX vs. VRTX - Performance Comparison
Loading charts...
Different Trading Currencies
MP1.AX is traded in AUD, while VRTX is traded in USD. To make them comparable, the VRTX values have been converted to AUD using the latest available exchange rates.
Returns By Period
In the year-to-date period, MP1.AX achieves a 36.48% return, which is significantly higher than VRTX's -12.86% return. Over the past 10 years, MP1.AX has outperformed VRTX with an annualized return of 22.24%, while VRTX has yielded a comparatively lower 16.59% annualized return.
MP1.AX
- 1D
- 0.00%
- 1M
- 84.35%
- YTD
- 36.48%
- 6M
- 27.97%
- 1Y
- 23.49%
- 3Y*
- 32.38%
- 5Y*
- 2.17%
- 10Y*
- 22.24%
VRTX
- 1D
- 0.00%
- 1M
- -1.28%
- YTD
- -12.86%
- 6M
- -15.61%
- 1Y
- -14.27%
- 3Y*
- 5.42%
- 5Y*
- 16.91%
- 10Y*
- 16.59%
MP1.AX vs. VRTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MP1.AX Megaport Limited | 36.48% | 65.13% | -19.89% | 45.80% | -66.00% | 30.25% | 32.68% | 193.44% | 7.65% | 40.50% |
VRTX Vertex Pharmaceuticals Incorporated | -11.56% | 4.41% | 8.93% | 41.01% | 40.19% | -1.64% | -1.54% | 32.74% | 22.43% | 87.93% |
Correlation
The correlation between MP1.AX and VRTX is -0.15, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.05 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.05 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.01 |
Correlation (All Time) Calculated using the full available price history since Dec 18, 2015 | -0.01 |
The correlation between MP1.AX and VRTX shifts across timeframes, from -0.15 (1 year) to -0.01 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MP1.AX vs. VRTX — Risk / Return Rank
MP1.AX
VRTX
MP1.AX vs. VRTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Megaport Limited (MP1.AX) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MP1.AX | VRTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.81 | ||
| Sortino ratioReturn per unit of downside risk | +1.37 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 0.94 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 0.38 | -0.61 | +0.99 |
| Martin ratioReturn relative to average drawdown | 0.76 | -1.14 | +1.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MP1.AX | VRTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.37 | -0.44 | +0.81 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.03 | 0.59 | -0.56 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.39 | 0.51 | -0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.37 | +0.02 |
Drawdowns
MP1.AX vs. VRTX - Drawdown Comparison
The maximum MP1.AX drawdown since its inception was -81.90%, which is greater than VRTX's maximum drawdown of -67.42%. Use the drawdown chart below to compare losses from any high point for MP1.AX and VRTX.
Loading charts...
Drawdown Indicators
| MP1.AX | VRTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.90% | -67.42% | -14.48% |
Max Drawdown (1Y)Largest decline over 1 year | -62.11% | -23.30% | -38.81% |
Max Drawdown (3Y)Largest decline over 3 years | -62.11% | -30.98% | -31.13% |
Max Drawdown (5Y)Largest decline over 5 years | -81.90% | -30.98% | -50.92% |
Max Drawdown (10Y)Largest decline over 10 years | -81.90% | -46.54% | -35.36% |
Current DrawdownCurrent decline from peak | -24.09% | -27.29% | +3.20% |
Average DrawdownAverage peak-to-trough decline | -33.51% | -17.99% | -15.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.91% | 12.51% | +18.40% |
Volatility
MP1.AX vs. VRTX - Volatility Comparison
Megaport Limited (MP1.AX) has a higher volatility of 27.27% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 6.58%. This indicates that MP1.AX's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MP1.AX | VRTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.27% | 6.58% | +20.69% |
Volatility (6M)Calculated over the trailing 6-month period | 52.84% | 20.43% | +32.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 62.86% | 32.89% | +29.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.17% | 28.91% | +37.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 57.47% | 32.56% | +24.91% |
Dividends
MP1.AX vs. VRTX - Dividend Comparison
Neither MP1.AX nor VRTX has paid dividends to shareholders.
Financials
MP1.AX vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between Megaport Limited and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MP1.AX and VRTX have a correlation of -0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for MP1.AX and VRTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer